We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

32 hedge funds and large institutions have $8.44M invested in Assembly Biosciences in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 12 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 32 → 32 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0.16% less ownership

Funds ownership: 1.67% → 1.51% (-0.16%)

30% less capital invested

Capital invested by funds: $12M → $8.44M (-$3.59M)

75% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 12

Holders
32
Holders Change
–
Holders Change %
0%
% of All Funds
0.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
3
Reduced
12
Closed
2
Calls
$9K
Puts
–
Net Calls
+$9K
Net Calls Change
-$8K

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$45.1K
2
XT
XTX Topco
Cayman Islands
+$25.3K
3
JP Morgan Chase
JP Morgan Chase
New York
+$60
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$48
5
Wells Fargo
Wells Fargo
California
+$12

Top Sellers

1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$629K
2
Renaissance Technologies
Renaissance Technologies
New York
-$205K
3
Millennium Management
Millennium Management
New York
-$36.9K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$33.9K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$30.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.98M -$33.9K -2,814 -1%
AIM
2
Alerce Investment Management
Illinois
$1.97M – – –
Millennium Management
3
Millennium Management
New York
$1.25M -$36.9K -3,066 -3%
BlackRock
4
BlackRock
New York
$940K -$7.68K -637 -0.7%
Renaissance Technologies
5
Renaissance Technologies
New York
$437K -$205K -17,026 -29%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$430K -$22.5K -1,865 -4%
Federated Hermes
7
Federated Hermes
Pennsylvania
$303K – – –
Hudson Bay Capital Management
8
Hudson Bay Capital Management
Connecticut
$177K -$629K -52,206 -76%
BCM
9
Bridgeway Capital Management
Texas
$154K – – –
State Street
10
State Street
Massachusetts
$129K – – –
Citadel Advisors
11
Citadel Advisors
Florida
$123K +$45.1K +3,743 +48%
Fidelity Investments
12
Fidelity Investments
Massachusetts
$121K -$3.63K -301 -3%
Northern Trust
13
Northern Trust
Illinois
$95.7K – – –
Acadian Asset Management
14
Acadian Asset Management
Massachusetts
$73K -$30.5K -2,532 -27%
Franklin Resources
15
Franklin Resources
California
$57.9K -$17.3K -1,438 -21%
Morgan Stanley
16
Morgan Stanley
New York
$39.6K -$72 -6 -0.2%
Barclays
17
Barclays
United Kingdom
$31.8K – – –
Charles Schwab
18
Charles Schwab
California
$28.7K – – –
XT
19
XTX Topco
Cayman Islands
$22.3K +$25.3K +2,103 New
Commonwealth Equity Services
20
Commonwealth Equity Services
Massachusetts
$16K -$265 -22 -1%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$14K – – –
RC
22
RBF Capital
California
$13K – – –
Two Sigma Advisers
23
Two Sigma Advisers
New York
$11.5K -$1.92K -159 -13%
HSBC Holdings
24
HSBC Holdings
United Kingdom
$10.2K – – –
EGM
25
Engineers Gate Manager
New York
$8.91K – – –
1
2

ASMB Hedge Fund Activity: Q3 2023 in Review

32 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q3 2023, worth a combined $8.44M — down 30% from $12M a quarter earlier.

Fund positioning in ASMB was balanced in Q3 2023: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 12 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $45.1K. The largest seller was Hudson Bay Capital Management, cutting an estimated $629K.

  • 32 institutional investors held Assembly Biosciences (ASMB) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $8.44M of Assembly Biosciences stock for Q3 2023, down 30% quarter-over-quarter.
  • 2 funds opened new Assembly Biosciences positions in Q3 2023 and 2 closed out, a net change of 0 holders.
  • The largest Assembly Biosciences buyer in Q3 2023 was Citadel Advisors, an estimated $45.1K added.
  • The largest Assembly Biosciences seller in Q3 2023 was Hudson Bay Capital Management, an estimated $629K sold.

Based on aggregated 13F filings for Q3 2023.